KA

Karen Agersborg

Clinuvel Pharmaceuticals Limited | Non-Executive Director
Dr Agersborg has diverse and practice experience in Pennsylvania and New Jersey, USA. She is Board Certified in both Internal Medicine and Endocrinology, Diabetes & Metabolism and holds specific expertise on the class of melanocortins. Her career has included inpatient, outpatient, and hospitalist positions across several prominent medical institutions. Dr Agersborg had career in managing commercial sales & distribution at Wyeth Pharmaceuticals (formerly Ayerst Laboratories).

Company and Role

Company
Title
Tenure
Since
CUV
Clinuvel Pharmaceuticals Limited
  • Non-Executive Director
6yrs, 11mthJan 2018

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
CUV
Clinuvel Pharmaceuticals Limited
03/09/2411,233N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
CUV
Clinuvel Pharmaceuticals Limited
25/11/10
Issued
450,000$1.730$778,500Issue of securities. Performance Rights